These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10961717)

  • 1. Development of a multiple-marker RT-PCR assay for detection of micrometastases of hepatocellular carcinoma.
    Miyamoto A; Fujiwara Y; Sakon M; Nagano H; Sugita Y; Kondo M; Eguchi H; Dono K; Umeshita K; Nakamori S; Monden M
    Dig Dis Sci; 2000 Jul; 45(7):1376-82. PubMed ID: 10961717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of MAGE-1, MAGE-3 and AFP mRNA as multimarker by real-time quantitative PCR assay: a possible predictor of hematogenous micrometastasis of hepatocellular carcinoma.
    Zhang Y; Li Q; Liu N; Song T; Liu Z; Guo R; Meng L
    Hepatogastroenterology; 2008; 55(88):2200-6. PubMed ID: 19260505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of AFPmRNA and melanoma antigen gene-1mRNA as markers of disseminated hepatocellular carcinoma cells in blood.
    Yang SZ; Dong JH; Li K; Zhang Y; Zhu J
    Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):227-33. PubMed ID: 15908320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of alpha-fetoproteins mRNA and melanoma antigen-1 mRNA in peripheral blood of patients with hepatocellular carcinoma and its clinical significance].
    Yang SZ; Dong JH; Zhu J; Li K; Zhang Y
    Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(17):1060-3. PubMed ID: 15498320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
    Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
    ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of isolated disseminated tumor cells in bone marrow and blood samples of patients with hepatocellular carcinoma.
    Kienle P; Weitz J; Klaes R; Koch M; Benner A; Lehnert T; Herfarth C; von Knebel Doeberitz M
    Arch Surg; 2000 Feb; 135(2):213-8. PubMed ID: 10668884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of cancer-testis antigen mRNA in peripheral blood from hepatocellular carcinoma patients.
    Zhao L; Mou DC; Peng JR; Huang L; Wu ZA; Leng XS
    World J Gastroenterol; 2010 Aug; 16(32):4072-8. PubMed ID: 20731022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Perioperative detection of MAGE-1mRNA and AFP mRNA in peripheral blood of patients with hepatocellular carcinoma: relationships with recurrence].
    Yang SZ; Dong JH; Zhu J; Li K; Zhang Y
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(9):595-8. PubMed ID: 15949354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of alpha-fetoprotein and prostate-specific antigen genes in several tissues and detection of mRNAs in normal circulating blood by reverse transcriptase-polymerase chain reaction.
    Ishikawa T; Kashiwagi H; Iwakami Y; Hirai M; Kawamura T; Aiyoshi Y; Yashiro T; Ami Y; Uchida K; Miwa M
    Jpn J Clin Oncol; 1998 Dec; 28(12):723-8. PubMed ID: 9879288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of MAGE-B genes in hepatocellular carcinoma].
    Mou DC; Leng XS; Peng JR; Zhao L; Wang WX; Wang Y; Li T; Zhang LG; Huang L; Zhu JY
    Zhonghua Zhong Liu Za Zhi; 2004 Jan; 26(1):40-2. PubMed ID: 15059354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic detection of lymph node micrometastases in patients with gastric carcinoma by multiple-marker reverse transcriptase-polymerase chain reaction assay.
    Okada Y; Fujiwara Y; Yamamoto H; Sugita Y; Yasuda T; Doki Y; Tamura S; Yano M; Shiozaki H; Matsuura N; Monden M
    Cancer; 2001 Oct; 92(8):2056-64. PubMed ID: 11596020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells.
    Mou DC; Cai SL; Peng JR; Wang Y; Chen HS; Pang XW; Leng XS; Chen WF
    Br J Cancer; 2002 Jan; 86(1):110-6. PubMed ID: 11857021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells].
    Li BD; Zhao QC; Zhu YT; Zhang FQ; Dou KF
    Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):458-62. PubMed ID: 16772080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of MAGE genes and survival in patients with hepatocellular carcinoma.
    Suzuki K; Tsujitani S; Konishi I; Yamaguchi Y; Hirooka Y; Kaibara N
    Int J Oncol; 1999 Dec; 15(6):1227-32. PubMed ID: 10568832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Melanoma antigen-3 expression in human hepatocellular carcinoma].
    Cai S; Zhao H; Leng X; Cheng J; Gong S; Peng J; Cong X; Wang Y; Rui J; Hui Y; Du R; Chen W
    Zhonghua Wai Ke Za Zhi; 2000 Sep; 38(9):693-6. PubMed ID: 11832142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accurate molecular detection of melanoma nodal metastases: an assessment of multimarker assay specificity, sensitivity, and detection rate.
    Davids V; Kidson SH; Hanekom GS
    Mol Pathol; 2003 Feb; 56(1):43-51. PubMed ID: 12560463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and clinical significance of MAGE-4 gene in human hepatocellular carcinoma].
    Zhao H; Rui J; Cong X; Zhao Y; Wang S; Chen S; Wang Y; Wang Y; Leng X; Chen W
    Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):100-2. PubMed ID: 11983123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AFP mRNA level in enriched circulating tumor cells from hepatocellular carcinoma patient blood samples is a pivotal predictive marker for metastasis.
    Jin J; Niu X; Zou L; Li L; Li S; Han J; Zhang P; Song J; Xiao F
    Cancer Lett; 2016 Aug; 378(1):33-7. PubMed ID: 27160647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mRNA of MAGE genes as specific markers in detection of tumor cells in the peripheral blood of patients with hepatocellular carcinoma.
    Peng J; Cai S; Leng X; Mu D; Lu J; Chen H; Rui J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Dec; 36(7):487-90. PubMed ID: 12411150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semiquantification of circulating hepatocellular carcinoma cells by reverse transcriptase polymerase chain reaction.
    Wong IH; Leung T; Ho S; Lau WY; Chan M; Johnson PJ
    Br J Cancer; 1997; 76(5):628-33. PubMed ID: 9303362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.